CMPX
Price
$2.69
Change
-$0.04 (-1.47%)
Updated
Mar 4, 11:00 AM (EDT)
Capitalization
399.01M
69 days until earnings call
FHTX
Price
$4.06
Change
-$0.26 (-6.02%)
Updated
Mar 4, 11:01 AM (EDT)
Capitalization
269.72M
2 days until earnings call
Ad is loading...

CMPX vs FHTX

Header iconCMPX vs FHTX Comparison
Open Charts CMPX vs FHTXBanner chart's image
Compass Therapeutics
Price$2.69
Change-$0.04 (-1.47%)
Volume$974
Capitalization399.01M
Foghorn Therapeutics
Price$4.06
Change-$0.26 (-6.02%)
Volume$200
Capitalization269.72M
CMPX vs FHTX Comparison Chart
Loading...
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CMPX vs. FHTX commentary
Mar 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMPX is a Buy and FHTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 04, 2025
Stock price -- (CMPX: $2.72 vs. FHTX: $4.34)
Brand notoriety: CMPX and FHTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMPX: 56% vs. FHTX: 78%
Market capitalization -- CMPX: $399.01M vs. FHTX: $269.72M
CMPX [@Biotechnology] is valued at $399.01M. FHTX’s [@Biotechnology] market capitalization is $269.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $398.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.48B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMPX’s FA Score shows that 0 FA rating(s) are green whileFHTX’s FA Score has 0 green FA rating(s).

  • CMPX’s FA Score: 0 green, 5 red.
  • FHTX’s FA Score: 0 green, 5 red.
According to our system of comparison, CMPX is a better buy in the long-term than FHTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMPX’s TA Score shows that 3 TA indicator(s) are bullish while FHTX’s TA Score has 4 bullish TA indicator(s).

  • CMPX’s TA Score: 3 bullish, 5 bearish.
  • FHTX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both CMPX and FHTX are a bad buy in the short-term.

Price Growth

CMPX (@Biotechnology) experienced а -12.54% price change this week, while FHTX (@Biotechnology) price change was -15.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.35%. For the same industry, the average monthly price growth was -11.04%, and the average quarterly price growth was -7.19%.

Reported Earning Dates

CMPX is expected to report earnings on May 12, 2025.

FHTX is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-5.35% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CMPX($399M) has a higher market cap than FHTX($270M). CMPX YTD gains are higher at: 87.586 vs. FHTX (-8.051). CMPX has higher annual earnings (EBITDA): -53.58M vs. FHTX (-98.53M). FHTX has more cash in the bank: 267M vs. CMPX (135M). CMPX has less debt than FHTX: CMPX (6.88M) vs FHTX (39.1M). FHTX has higher revenues than CMPX: FHTX (25.5M) vs CMPX (850K).
CMPXFHTXCMPX / FHTX
Capitalization399M270M148%
EBITDA-53.58M-98.53M54%
Gain YTD87.586-8.051-1,088%
P/E RatioN/AN/A-
Revenue850K25.5M3%
Total Cash135M267M51%
Total Debt6.88M39.1M18%
TECHNICAL ANALYSIS
Technical Analysis
CMPXFHTX
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 27 days ago
86%
Bullish Trend 20 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Ad is loading...
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FHTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OSTVX16.55N/A
N/A
Osterweis Growth & Income Fund
BGRFX88.70N/A
N/A
Baron Growth Retail
FIQKX11.14N/A
N/A
Fidelity Advisor International Value Z
GFFDX82.37-1.11
-1.33%
Invesco Global Focus R5
ISGNX14.16-0.57
-3.87%
Columbia Integrated Small Cap Gr Instl

CMPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMPX has been loosely correlated with VCYT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CMPX jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMPX
1D Price
Change %
CMPX100%
-6.21%
VCYT - CMPX
37%
Loosely correlated
-3.45%
FHTX - CMPX
36%
Loosely correlated
-10.52%
VIR - CMPX
36%
Loosely correlated
-5.60%
IPSC - CMPX
35%
Loosely correlated
-10.08%
SANA - CMPX
34%
Loosely correlated
-6.51%
More

FHTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, FHTX has been loosely correlated with ABOS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if FHTX jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FHTX
1D Price
Change %
FHTX100%
-10.52%
ABOS - FHTX
50%
Loosely correlated
-10.16%
AVIR - FHTX
48%
Loosely correlated
-4.13%
AURA - FHTX
44%
Loosely correlated
-3.74%
ATXS - FHTX
44%
Loosely correlated
-4.97%
XNCR - FHTX
42%
Loosely correlated
-5.60%
More